Material
The ABO groups of 303 patients with infantile hypertrophic pyloric stenosis were determined as part of a follow-up study. In all instances the diagnosis had been confirmed at operation, and all patients were resident in Belfast or its immediate environs at that time.
Information concerning the distribution of the ABO blood groups in Belfast was obtained from the Serological Population Genetics Laboratory (A. C. Kope6, personal communication, 1967) and used for control purposes.
The salivary secretor status of 288 patients with infantile hypertrophic pyloric stenosis was investigated. Control data were obtained from 96 children admitted to hospital for tonsillectomy or adenoidectomy and from 435 children attending school dental clinics in Belfast.
Methods
Blood samples were obtained by venepuncture except in a small number of infants, when capillary blood obtained by heel stab was used. In all cases a full explanation was given to the parents, and in no instance was permission for blood sampling refused. ABO blood groups were determined by the tube method.
Samples of saliva were examined for the presence of ABH blood group substances. The children were asked to rinse their mouths with water before saliva was collected into plastic specimen jars and transferred to test-tubes. In the case of infants saliva was aspirated gently with a 2-ml. syringe. The tubes were partly immersed in a boiling water-bath for 10 to 20 minutes before being stoppered and stored in a refrigerator at 40 C. until testing, which was usually within 24 hours. Saliva specimens were tested for the presence of A, B, and H substances by the method of Dunsford and Bowley (1955 The incidence of salivary non-secretors was lower than expected, but this is not significant (0.1<P<0.2) ( Table III) . The secretor status of the blood group controls is not known, so Table IV gives a calculated expected incidence of each blood group and secretor type combination, compared with the observed incidence in infantile pyloric stenosis, but no claim is made that these results are statistically valid. Group AB non-secretor .
. 0-66 1I04 * Blood group data were obtained from the Serological Population Genetics Laboratory. As the secretor status of these donors was not known, the expected incidence of each blood group and secretor/non-secrctor combination has been calculated by using the observed secretor/non-secretor ratio in the child controls referred to in Table III .
Discussion
It has been stated that infants with hypertrophic pyloric stenosis have a high incidence of peptic ulcer in later life (Bendix and Necheles, 1947; Belding and Kernohan, 1953; Hecker, Wenz, and Bruckner, 1966) , though control data are difficult to obtain. If this were so one might expect to find an increased incidence of blood group 0 among babies with pyloric stenosis, such as is seen in adult ulcer patients. Indeed, it is possible that the pyloric hypertrophy develops in association with a juxtapyloric ulcer occurring in the neonatal period, for there is no apparent reason why newborn infants should not be equally subject to peptic ulcer as adults (Polacek and Ellison, 1966) . Burge, Gill, and Lewis (1963) suggest that hypertrophic pyloric stenosis in adults is always related to ulceration in or near the pylorus, a view which was earlier put forward by Golden (1937) .
The present series certainly demonstrates an excess of group 0 patients when compared with those of group A, of the same order as that seen in several series of duodenal ulcer patients (Clarke, 1964b) . However, this apparent excess of group 0 patients is actually a reduced incidence of persons of group A, a deficiency which is largely compensated by the marked increase in the proportion of group B patients in the series. Thus group A may be regarded as in some way protecting against the development of infantile pyloric stenosisor, alternatively, both group 0 and group B infants are at greater risk than those of group A (Table II) . Though the group 0 babies would also have a theoretically greater chance of developing an ulcer, no association between group B and peptic ulcer has been reported.
Non-secretors of group 0 are particularly liable to develop peptic ulcers (Clarke, Price Evans, McConnell, and Sheppard, 1959) . In this series secretor status appears to be unrelated to the occurrence of pyloric stenosis.
The blood group distribution seen in infantile hypertrophic pyloric stenosis may be compared with that found in relation to the production of alkaline phosphatase by the gut after a fatty meal. It has been shown that persons of groups 0 and B produce more of this type of alkaline phosphatase than those of groups AB and A (Arfors, Beckman, and Lundin, 1963a) . Thus individuals of groups 0 and B not only produce more intestinal alkaline phosphatase than those of group A but would also appear to have a greater susceptibility to infantile pyloric stenosis. It is known that secretors of ABH substances produce more intestinal alkaline phosphatase than non-secretors of the same blood group (Arfors, Beckman, and Lundin, 1963b) . Thus secretors of groups 0 and B produce most alkaline phosphatase, followed by 0 and B non-secretors, with group A non-secretors producing least of all. Though not statistically significant, such evidence as this present study provides does suggest that (except in the case of group A) salivary ABH secretors are at greater risk of developing infantile pyloric stenosis than nonsecretors. The series is too small to allow firm conclusions to be drawn in this respect, and no information is yet available about the secretion of alkaline phosphatase in pyloric stenosis.
Summary
Analysis of the ABO blood groups of 303 patients with infantile hypertrophic pyloric stenosis showed a significantly low incidence of group A compared with controls. The blood group distribution is discussed in relation to the quantitative differences in intestinal alkaline phosphatase found in persons of different ABO groups.
Investigation of salivary ABH secretor status showed no significant difference between patients with infantile pyloric stenosis and controls.
